Washington, DC (PRWEB) October 02, 2012
FierceMedicalDevices (http://www.fiercemedicaldevices.com) today is rolling out its first annual “Fierce 15” list of the top privately held medical device and diagnostic companies of 2012. FierceMedicalDevices Editors Mark Hollmer and Damian Garde, in conjunction with Editor-in-Chief John Carroll and Executive Editor Ryan McBride, chose this year's winners based on their top management teams, notable financial backing, and promising technologies and market opportunities.
"These medical device and diagnostic companies will be the ones to watch in the coming months and years,” said Hollmer. “In areas including tissue regeneration, heart failure, migraine treatments, obesity and infection control, they are both raising and changing the standard of care for the better," added Garde.
An internationally recognized daily e-newsletter reaching more than 34,000 medical device and diagnostic industry professionals, FierceMedicalDevices provides subscribers with a quick authoritative briefing on the day's top stories, with a special focus on clinical studies, FDA/EMEA regulations, and mergers and acquisitions. Sign up is free at http://www.fiercemedicaldevices.com/signup.
The "Fierce 15" champions innovation and creativity, even in the face of intense competition.
The 2012 Fierce 15 winners are:
1. Apollo Endosurgery
2. Autonomic Technologies
3. CardioDx
4. CardioKinetix
5. EndoSphere
6. Histogenics
7. IntraPace
8. Nevro
9. NinePoint Medical
10. Orthocare Innovations
11. PrimeraDx
12. Proteus Digital Health
13. Tyrx
14. T2 Biosystems
15. Vessix Vascular